Aligos Therapeutics Inc. (ALGS) Misses Q2 EPS by 153c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q2 EPS of ($1.53).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenable Holdings, Inc. (TENB) to Join S&P SmallCap 600
- JPMorgan Starts Toho Co Ltd. (9602:JP) (TKCOF) at Overweight
- Nomura/Instinet Upgrades YTL Power International (YTLP:MK) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
